Mesenchymal Stem Cells Market
The growing clinical use of mesenchymal stem cells for the treatment of autoimmune diseases, bone and cartilage diseases, and chronic diseases is anticipated to drive the global mesenchymal stem cells market. According to studies, these stem cells promote angiogenesis in the myocardium and enable the reduction of fibrotic myocardial tissue. Mesenchymal stem cells are expected to gain new market share as a result of pre-clinical research examining their potential for treating cancer, liver, and cardiovascular diseases. Additionally, mesenchymal stem cells create anti-inflammatory molecules that control cellular and humoral immune responses.
Read More:
https://knackersblogger.blogspot.com/2022/11/mesenchymal-stem-cells-market-global.html
